Investment analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued on Friday. The brokerage set a “sell” rating on the stock.
SenesTech Stock Down 4.8 %
Shares of NASDAQ SNES opened at $2.80 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.68 and a quick ratio of 3.49. The stock has a fifty day simple moving average of $2.83 and a two-hundred day simple moving average of $4.99. SenesTech has a 1-year low of $1.90 and a 1-year high of $45.60.
SenesTech (NASDAQ:SNES – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($3.08) earnings per share for the quarter, topping the consensus estimate of ($3.20) by $0.12. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. The company had revenue of $0.46 million during the quarter, compared to the consensus estimate of $0.49 million. During the same quarter in the prior year, the company earned ($84.03) EPS. Sell-side analysts expect that SenesTech will post -11 EPS for the current fiscal year.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- Investing in the High PE Growth Stocks
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Consumer Discretionary Stocks Explained
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What is an Earnings Surprise?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
